Datum: 15.3.2023
Summary:
A Spanish healthcare research institute has developed silica particles for nucleic acid encapsulation, which are able to transport and transfer gen therapies and proteins into cells. In addition, they are stable at room temperature, versatile and cost-effective.
The Institute is looking for companies interested in the use of this patent protected silica particles to cooperate in the framework of a commercial agreement with technical assistance or a research and development agreement.
Reference: TOES20230331019
Country: Spain
Submitted: 3. 4. 2023
Keywords
Technology: Biological Nanomaterials; Cellular and Molecular Biology; Human vaccines; Gene Expression, Proteome Research; Gene - DNA Therapy.
Market: Micro- and Nanotechnology related to Biological sciences; Cellular and Molecular Biology; Gene Expression, Proteome Research; Genetic Engineering; Molecular design.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Plant Biotechnology - plant biotechnology
Věda - Dějiny vědy, historie vědy na Wikipedii
VakcĂna ve spreji zatoÄŤĂ s ĂşpornĂ˝mi infekcemi moÄŤovĂ˝ch cest
Organoidy varlat přispějà k výzkumu neplodnosti